Thus, the potentially competitive effects of murine tumor antigen presentation must be considered when testing the HPV antigen-specific CD8+ T cell-mediated immune responses in HLA-A2 (AAD) transgenic mice. The gene discussed is CD8A; the disease is neoplasm.